Skip to main content
. 2015 Jun 17;10(6):e0129922. doi: 10.1371/journal.pone.0129922

Fig 1. Flowchart of patient selection.

Fig 1

CKD, chronic kidney disease; ESA, erythropoiesis-stimulating agent; TZD, thiazolidinedione.